Analyst Ratings For NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)
Today, NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) stock was downgraded by UBS from Buy ➝ Neutral to with a price target of $57.00.
Some recent analyst ratings include
- 5/21/2018-UBS was Downgraded by analysts at UBS from a “Buy ➝ Neutral” rating to a “” rating. They now have a $57.00 price target on the stock.
- 4/27/2018-BMO Capital Markets Upgrade from a “Underperform ➝ Market Perform” rating to a “” rating.
- 4/20/2018-Cowen Reiterated Rating of Hold.
- 4/17/2018-William Blair Reiterated Rating of Outperform.
Dividend information for NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)
NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) pays an annual dividend of $1.60 with a yield of 3.04% and an average dividend growth of 2.70% based on a 3 Year Average..
Dividend History for NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)
- On 3/1/2018 NYSE:BMY – Bristol-Myers Squibb announced a quarterly dividend of $0.40 2.43568275232151% with an ex dividend date of 4/5/2018 which will be payable on 5/1/2018.
- On 12/7/2017 NYSE:BMY – Bristol-Myers Squibb announced a quarterly dividend of $0.40 2.56% with an ex dividend date of 1/4/2018 which will be payable on 2/1/2018.
- On 9/13/2017 NYSE:BMY – Bristol-Myers Squibb announced a quarterly dividend of $0.39 2.49% with an ex dividend date of 10/5/2017 which will be payable on 11/1/2017.
- On 6/13/2017 NYSE:BMY – Bristol-Myers Squibb announced a quarterly dividend of $0.39 2.86% with an ex dividend date of 7/5/2017 which will be payable on 8/1/2017.
- On 3/2/2017 NYSE:BMY – Bristol-Myers Squibb announced a quarterly dividend of $0.39 2.72% with an ex dividend date of 4/5/2017 which will be payable on 5/1/2017.
- On 12/8/2016 NYSE:BMY – Bristol-Myers Squibb announced a quarterly dividend of $0.39 2.73% with an ex dividend date of 1/4/2017 which will be payable on 2/1/2017.
- On 8/3/2016 NYSE:BMY – Bristol-Myers Squibb announced a quarterly dividend of $0.38 2.02% with an ex dividend date of 10/5/2016 which will be payable on 11/1/2016.
Recent Insider Trading Activity For NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)
NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY) has insider ownership of 0.12% and institutional ownership of 71.29%.
- On 4/30/2018 Dinesh C Paliwal, Director, bought 4,770 with an average share price of $52.40 per share and the total transaction amounting to $249,948.00.
- On 12/15/2017 Theodore R Samuels II, Director, bought 4,000 with an average share price of $62.30 per share and the total transaction amounting to $249,200.00.
- On 12/12/2017 Thomas J Jr. Lynch, EVP, sold 5,300 with an average share price of $63.24 per share and the total transaction amounting to $335,172.00.
- On 12/4/2017 Sandra Leung, EVP, sold 156,582 with an average share price of $63.37 per share and the total transaction amounting to $9,922,601.34.
- On 9/6/2017 Joseph C Caldarella, SVP, sold 9,340 with an average share price of $60.00 per share and the total transaction amounting to $560,400.00.
- On 8/2/2017 Theodore R Samuels II, Director, bought 6,000 with an average share price of $55.94 per share and the total transaction amounting to $335,640.00.
- On 4/7/2017 Lamberto Andreotti, Director, sold 34,000 with an average share price of $53.26 per share and the total transaction amounting to $1,810,840.00.
Recent Trading Activity for NYSE:BMY – Bristol-Myers Squibb (NYSE:BMY)
Shares of NYSE:BMY – Bristol-Myers Squibb closed the previous trading session at 52.61 down -0.10 0.19% with shares trading hands.